Format

Send to

Choose Destination
Inflamm Bowel Dis. 2013 Jun;19(7):1506-13. doi: 10.1097/MIB.0b013e318281f520.

Patient perceptions of fecal microbiota transplantation for ulcerative colitis.

Author information

1
Section of Pediatric Gastroenterology, Hepatology, and Nutrition, University of Chicago, 5841 South Maryland Avenue, MC 4065, Chicago, IL 60637, USA. skahn@peds.bsd.uchicago.edu

Abstract

BACKGROUND:

Fecal microbiota transplantation (FMT), the delivery of stool from a healthy prescreened donor to an individual with disease, is gaining increasing recognition as a potential treatment for inflammatory bowel diseases. Our objective was to describe patient interest in and social concerns around FMT.

METHODS:

We conducted a survey of adults with ulcerative colitis (UC) seen in outpatient clinic at the University of Chicago IBD Center. All English-speaking patients ≥18 years of age were eligible. Subjects completed a written survey in clinic. Ninety-five participants, median age 39 years, 53% female, were enrolled in the study.

RESULTS:

Forty-four percent and 49% reported excellent or good/satisfactory medical management of their UC, respectively. Forty-six percent participants were willing to undergo FMT as a treatment of UC, 43% were unsure, and 11% were unwilling to undergo FMT. Subjects who had been hospitalized were more willing to undergo FMT, 54% versus 34%, P = 0.035. Primary concerns included the following: adequate screening for infections (41%), cleanliness (24%), and potential to worsen UC (18%); 21% reported no specific concerns. For donor selection, an equal number of participants (46%) preferred whomever their doctor recommended or family member/spouse.

CONCLUSIONS:

In our center despite reporting satisfactory to excellent disease control with their treatments, the vast majority of patients with UC are interested in or willing to consider FMT. Proof of safety and effectiveness, and failure of other medical therapies are key issues in considering FMT. Strong interest in this as-yet unproven therapy warrants attention and is a pressing priority for clinical research and education.

PMID:
23624888
PMCID:
PMC3780382
DOI:
10.1097/MIB.0b013e318281f520
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center